sarafloxacin has been researched along with E coli Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chansiripornchai, N; Sasipreeyajan, J | 1 |
| Erwin, ME; Jones, RN | 1 |
| Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N | 1 |
1 trial(s) available for sarafloxacin and E coli Infections
| Article | Year |
|---|---|
Efficacy of sarafloxacin in broilers after experimental infection with Escherichia coli.
Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Escherichia coli Infections; Female; Fluoroquinolones; Male; Poultry Diseases | 2002 |
2 other study(ies) available for sarafloxacin and E coli Infections
| Article | Year |
|---|---|
In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Infection Control; Microbial Sensitivity Tests; Poultry Diseases; Quality Control | 1998 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Immunosuppression Therapy; Klebsiella Infections; Mice; Norfloxacin; Piperazines; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Quinolines; Salmonella Infections, Animal; Staphylococcal Infections; Streptococcal Infections | 1986 |